Rare diseases
Investigational molecules
Locations
Back to Germany1 819 clinical trials in Potsdam, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis
GermanyStudy on the Safety and Effectiveness of Giroctocogene Fitelparvovec for Adult Men with Moderate to Severe Hemophilia A
GermanyStudy on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors
GermanyStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
GermanyStudy of Eltrekibart for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
GermanyStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
GermanyStudy on Ianalumab for Patients with Systemic Lupus Erythematosus
GermanyLong-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A
GermanyStudy on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis
GermanyStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
GermanyStudy on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies for triple-negative, HER2-positive, and hormone receptor-positive variants. Research encompasses new combination therapies and targeted treatments.
Multiple studies are evaluating novel drug combinations and personalized therapeutic approaches.
Clinical research targeting various skin conditions, including atopic dermatitis and chronic skin disorders. Studies focus on both topical and systemic treatments.
Investigations include both traditional and innovative therapeutic approaches for skin conditions.
Studies focusing on multiple sclerosis treatment options, evaluating new medications and comparing their effectiveness to existing therapies.
Research aims to improve treatment outcomes and quality of life for patients with neurological conditions.
Research focusing on cardiovascular disease management and innovative treatments for related conditions, including studies on lipid management.
Trials aim to reduce major cardiovascular events and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
